Filter
1140
Filtered Results: 1140
Text search:
therapeutic
agents
Featured
Recommendations
145
New Publications
286
Language
Document type
No document type
560
Guidelines
256
Studies & Reports
189
Manuals
62
Strategic & Response Plan
24
Fact sheets
17
Training Material
16
Situation Updates
9
Brochures
2
Resource Platforms
2
Infographics
2
Online Courses
1
Countries / Regions
India
76
South Africa
46
Global
41
Kenya
37
Ethiopia
27
Uganda
21
Nigeria
20
Zambia
19
Tanzania
19
Latin America and the Carribbean
17
Nepal
16
Western and Central Europe
16
Sierra Leone
15
Bangladesh
15
Liberia
13
Ghana
12
Rwanda
12
Philippines
11
Namibia
11
Myanmar / Burma
10
Congo, Democratic Republic of
9
Africa
8
Burkina Faso
7
Cambodia
7
Mozambique
7
Russia
7
Germany
6
Malawi
6
Brazil
6
Lesotho
6
USA
5
Cameroon
5
Zimbabwe
5
Indonesia
5
Ukraine
5
Guinea
4
Senegal
4
Mali
4
Haiti
4
Syria
4
Thailand
4
Benin
4
West and Central Africa
4
Middle East and North Africa
4
Eastern Europe
4
Eswatini/ Swaziland
3
North Macedonia
3
Yemen
3
East and Southern Africa
3
South–East Asia Region
3
Eastern Europe and Central Asia
3
Asia
3
Venezuela
3
Vietnam
3
France
3
Spain
3
Pakistan
2
South Sudan
2
Iraq
2
Afghanistan
2
China
2
Sudan
2
Botswana
2
Libya
2
Angola
2
Madagascar
2
Western Pacific Region
2
Paraguay
2
Fiji
2
Bhutan
2
Laos
2
Tajikistan
2
Georgia
2
Gabon
2
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Niger
1
Somalia
1
Jordan
1
Turkey
1
Malaysia
1
Singapore
1
Papua New Guinea
1
Central African Republic
1
Argentina
1
Peru
1
Serbia
1
Colombia
1
Sri Lanka
1
Other region
1
Solomon Islands
1
Albania
1
Armenia
1
Congo-Brazzaville
1
Estonia
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
North America
1
Turkmenistan
1
Denmark
1
Maldives
1
Mauritius
1
United Kingdom
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
442
Clinical Guidelines
171
Public Health
58
Women & Child Health
46
Key Resources
33
Pharmacy & Technologies
18
Capacity Building
12
Toolboxes
AMR
167
COVID-19
82
Mental Health
79
Pharmacy
78
HIV
61
TB
58
NCDs
37
Ebola
36
Caregiver
32
NTDs
32
Rapid Response
31
Planetary Health
16
Disability
12
Refugee
12
Conflict
9
Natural Hazards
8
Specific Hazards
7
Cholera
5
Global Health Education
4
Zika
3
Polio
2
Social Ethics
2
Health Financing Toolbox
2
April 2022 Volume 35 Issue 2 e00152-21
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where t...
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 117: e200460, 2022
Integrating the multiple dimensions of the problem into a coherent approach adapted to field realities and needs represents an immense challenge, but the payoff is more effective and sustainable experiences, with higher social awareness...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
PLoS Negl Trop Dis 15(8): e0009697. Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses t...
Este manual se ha elaborado en el marco de la Iniciativa Global de la Organización Mundial de la Salud (OMS) para el Cáncer Infantil, CureAll Americas, con el propósito de mejorar la situación de los niños, niñas y adolescentes con cáncer en todo el mundo, para que puedan tener las mejores po...
Mali national action plan on antimicrobial resistance: review of progress in the human health sector
This policy brief aims to provide a review of the current progress on implementing the Mali national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing act...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines ...
J Glob Health Sci. 2020 Jun;2(1):e3. A group of enzootic and zoonotic protozoan infections, the leishmaniases constitute among the most severely neglected tropical diseases (NTDs) and are found in all continents except Oceania. Representing the most common infectious diseases, NTDs comprise an open-...
A System of Health Accounts 2011: Revised Edition provides an updated and systematic description of the financial flows related to the consumption of health care goods and services. As demands for information increase and more countries implement and institutionalise health accounts according to the...
The waves of yellow fever transmission in the Region of the Americas in 2016–2018 involved the largest number of human and epizootic cases to be reported in several decades. Yellow fever is a serious viral hemorrhagic disease that poses a challenge for health professionals. It requires early recog...
In 2014, the World Heart Federation (WHF) launched
an initiative to develop a series of Roadmaps [1e6]. Their
aim is to identify potential roadblocks on the pathway to
effective prevention, detection, and management of cardiovascular disease (CVD), along with evidence-based
solutions to overcome...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
In 2012, all Member States of the World Health Organization (WHO) endorsed a historical target to reduce premature mortality from noncommunicable diseases
(NCD). This commitment was echoed in 2015 by the United Nations Sustainable Development Goals, which included a target to reduce premature morta...
A major problem facing the world is how to build peace following the ravages of increasingly protracted armed conflict. Armed conflicts leave behind shattered, divided societies that are at risk of repeating cycles of violence, and therefore need concerted peacebuilding efforts. Conflicts also take ...
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen...
Background
Low- and middle-income countries now experience the highest prevalence and mortality rates of cardiovascular disease.
Main text
While improving the availability and delivery of proven, effective therapies will no doubt mitigate this burden, we posit that studies evaluating cardiovasc...
The Infection Prevention and Control (IPC) Guidelines aim to support healthcare workers improve quality and safety health care. The Guidelines further aim to promote and facilitate the overall goal of IPC by providing evidence-based recommendations on the critical aspects of IPC, focusing on the fun...
It is now well known that there is a pandemic of Type 2 Diabetes in the world particularly in developing countries. This fact has several implications for the health care system in the developing countries because this condition is associated with metabolic and vascular complications which in turn i...
